R New Jersey General Assembly · District 30

Asm. Sean Kean

Contact Email Phone Official site ↗

Compare

Session

Total votes

5,049

all sessions

Attendance

86%

669 missed

Near the chamber average

With party

95%

of cast votes

Lower than 89% of chamber peers

Bipartisan score

3%

crosses aisle rarely

Higher than 85% of chamber peers

Voting record

Yea

3,428

voted in favor

Nay

764

voted against

Absent

669

missed votes

Total cast

5,049

across all sessions

Crossed party

178

votes against own party

This page

5,049

matching current filters

Bill

Description

Vote

Result

Tally

Date

A 1639

Increases personal needs allowance to $50 for recipients of Medicaid and Supplemental Security Income who are veterans or spouses of veterans and provides for annual cost-of-living increase in allowance.

Yea

Passed

69–0

Oct 20, 2016

A 747

Requires State Treasurer to organize and publish certain contract and grant data and information on State expenditure Internet website.

Yea

Passed

68–0

Oct 20, 2016

A 1185

Requires State Comptroller to report findings of audit compliance reviews.

Yea

Passed

69–0

Oct 20, 2016

AJR 87

Recognizes 100th anniversary of Farm Credit East Program.

Yea

Passed

69–0

Oct 20, 2016

A 224

Provides for licensing of pool and spa service contractors, and pool and spa builders and installers. Against party

Yea

Passed

51–12

Oct 20, 2016

AR 185

Authorizes Assembly Judiciary Committee to enter upon investigation or inquiry into financial and operating practices of NJ Transit; grants committee subpoena power.

Nay

Passed

49–21

Oct 20, 2016

AR 149

Urges United States Air Force to base F-35 fighter jets at 177th Fighter Wing in Atlantic City.

Other

Passed

65–0

Oct 20, 2016

A 2451

"Aid in Dying for the Terminally Ill Act"; permits qualified terminally ill patient to self-administer medication to end life in humane and dignified manner.

Nay

Passed

39–28

Oct 20, 2016

A 316

Requires an annual State debt affordability analysis be included in the State Debt Report.

Yea

Passed

64–5

Oct 20, 2016

S 2024

Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.

Yea

Passed

69–0

Oct 20, 2016